135 related articles for article (PubMed ID: 7689258)
1. Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use.
Taylor-Fishwick DA; Kahan M; Hiestand P; Ritter MA; Foxwell BM
Transplantation; 1993 Aug; 56(2):368-74. PubMed ID: 7689258
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
Rebollo A; Mérida I; Gómez J; Pitton C; Silva A; Martínez C; García A
Cytokine; 1995 Apr; 7(3):277-86. PubMed ID: 7543780
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness of preactivated B cells to IL-2 and IL-6. Effect of cyclosporine and rapamycin.
Hornung N; Raskova J; Raska K; Degiannis D
Transplantation; 1993 Oct; 56(4):985-90. PubMed ID: 7692641
[TBL] [Abstract][Full Text] [Related]
5. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
Mattila PS
Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
[No Abstract] [Full Text] [Related]
6. Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin.
Siekierka JJ
Immunol Res; 1994; 13(2-3):110-6. PubMed ID: 7539823
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
[No Abstract] [Full Text] [Related]
8. Inhibition of T and B lymphocyte proliferation by rapamycin.
Kay JE; Kromwel L; Doe SE; Denyer M
Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
[TBL] [Abstract][Full Text] [Related]
9. Effect of rapamycin on the expression of the IL-2 receptor (CD25).
Woerly G; Brooks N; Ryffel B
Clin Exp Immunol; 1996 Feb; 103(2):322-7. PubMed ID: 8565319
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of the immunosuppressant rapamycin.
Dumont FJ; Su Q
Life Sci; 1996; 58(5):373-95. PubMed ID: 8594303
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation.
Ryffel B; Willcocks JL; Brooks N; Woerly G
Immunopharmacology; 1995 Sep; 30(3):199-207. PubMed ID: 8557519
[TBL] [Abstract][Full Text] [Related]
12. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
13. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
[No Abstract] [Full Text] [Related]
14. Categorizing receptor-signaling pathways with FK 506 and rapamycin.
Hultsch T; Hohman RJ
Transplant Proc; 1991 Dec; 23(6):2961-3. PubMed ID: 1721328
[No Abstract] [Full Text] [Related]
15. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
[No Abstract] [Full Text] [Related]
16. Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin.
Luo H; Chen H; Daloze P; St-Louis G; Wu J
Clin Exp Immunol; 1993 Nov; 94(2):371-6. PubMed ID: 8222329
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro.
Kahan BD; Gibbons S; Tejpal N; Stepkowski SM; Chou TC
Transplantation; 1991 Jan; 51(1):232-9. PubMed ID: 1987692
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells.
Kim HS; Raskova J; Degiannis D; Raska K
Clin Exp Immunol; 1994 Jun; 96(3):508-12. PubMed ID: 8004821
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
Duncan JI
J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
Cooper MH; Gregory SH; Thomson AW; Fung JJ; Starzl TE; Wing EJ
Transplant Proc; 1991 Dec; 23(6):2957-8. PubMed ID: 1721326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
